Rising Pharmaceuticals to Support Phase 2 Clinical Trial of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19
Trial conducted at Columbia University will investigate potential of chloroquine phosphate to prevent symptomatic SARS-CoV-2 infections EAST BRUNSWICK N.J.–(BUSINESS WIRE)–Rising Pharma Holdings Inc., the pharmaceutical company now operating as Rising Pharmaceuticals, today announced the support of a Phase 2 clinical trial designed to determine the clinical efficacy of chloroquine phosphate (CQ) in preventing coronavirus disease […]
Rising Pharmaceuticals to Support Global Clinical Trial Conducted by the CROWN Collaborative (represented by Washington University School of Medicine in the US), Investigating an Innovative Approach to Protecting Essential Healthcare Workers
An international study named “CROWN CORONATION” aims to include up to 55,000 subjects and is designed to assess the effectiveness of multiple dose ranges of chloroquine to prevent SARS-CoV-2 infection in frontline healthcare workers EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–Rising Pharma Holdings Inc., the pharmaceutical company operating as Rising Pharmaceuticals, today announced that it is donating chloroquine […]
Rising Pharmaceuticals & Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy
Trial conducted at Memorial Sloan Kettering Cancer Center designed to evaluate potential risk reduction for patients at risk for coronavirus infection May 07, 2020 07:30 AM Eastern Daylight Time EAST BRUNSWICK N.J.–(BUSINESS WIRE)–Rising Pharma Holdings, Inc., operating as Rising Pharmaceuticals, today announced the donation of Hydroxychloroquine tablets in support of a Phase 2 randomized clinical […]
How 13 drugmakers have responded to the COVID-19 pandemic
Drugmakers have taken steps such as lowering insulin costs and waiving license restrictions on possible treatments in response to the COVID-19 pandemic. The companies have also cut staff and delayed mergers to protect themselves financially. Editor’s note: This is not an exhaustive list. Drugmakers are listed in alphabetical order. AbbVie waived license restrictions on an HIV drug […]
Coronavirus treatment: how to enroll in hydroxychloroquine study
The malaria drugs chloroquine and hydroxychloroquine have rapidly become top potential coronavirus treatments. But they lack any high-quality clinical evidence that shows they are effective against COVID-19. Dr. David Boulware, a University of Minnesota infectious disease professor, is running two experiments to test hydroxychloroquine in large controlled trials to determine the drug’s effectiveness. Both are now […]
Nationwide study of health practitioners, first responders examines use of anti-malarial drug to counter COVID-19
Sarah Lofgren’s voice had a tinge of excitement when she explained why the bright green dots on one scientific slide disappeared on the next. The co-investigator at the University of Minnesota Division of Infectious Disease and International Medicine showed how SARS, or severe acute respiratory syndrome, represented by those green dots, responded to all the […]